在良性前列腺增生患者中TP53基因,端粒长度和线粒体DNA的变化
Egija Zole1, Edgars Baumanis2, Lauma Freimane1
1Latvian Biomedical Research and Study Centre, Ratsupites Street 1, k-1, LV-1067 Riga, Latvia.
Biomedicines
|October 26, 2024
概括
良性前列腺增生 (BPH) 与更长的端粒和前列腺组织中线粒体DNA (mtDNA) 拷贝数量的增加有关. 这些衰老特征可能在BPH发育中起作用.
科学领域:
- 老年学是一门学科.
- 分子生物学分子生物学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 良性前列腺增生 (BPH) 是一种普遍的疾病,特别是在老年人群中.
- 衰老的特征,包括端粒长度 (TL) 和线粒体DNA复制数 (mtDNA CN),越来越多地被认为是它们在与年龄有关的疾病中的潜在作用.
- 研究BPH和衰老标志物之间的相互作用对于理解疾病发病过程至关重要.
研究的目的:
- 探索良性前列腺增生症 (BPH) 与关键衰老指标之间的关联:端粒长度 (TL),线粒体基因组复制号 (mtDNA CN).
- 在BPH的背景下,研究TP53基因和线粒体DNA (mtDNA) 中遗传变异的潜在参与.
- 通过将这些衰老特征与疾病存在联系起来,阐明BPH背后的分子机制.
主要方法:
- 分析了32名BPH患者和30名健康对照的前列腺组织和血液样本.
- 使用qPCR试验量化端粒长度 (TL) 和线粒体DNA复制数 (mtDNA CN).
- 下一代测序 (NGS) 用于完整的mtDNA基因组分析和TP53基因的桑格测序.
主要成果:
- 来自BPH患者的前列腺组织与他们的血细胞相比,表现出明显更长的端粒 (TL).
- 在BPH患者的前列腺组织中,相对于血液细胞,观察到显著更高的线粒体DNA复制数 (mtDNA CN).
- 虽然没有与BPH相关的TP53基因突变,但确定了几种独特的mtDNA突变和异质体变化,其中一些先前与前列腺癌相关.
结论:
- 延长的端粒和改变的mtDNA拷贝数似乎与良性前列腺增生症 (BPH) 的分子机制有关.
- 特定的异质体或同质体mtDNA变异可能有助于BPH的发展或进展.
- 需要进一步的研究来验证这些发现,并充分了解老化特征在BPH中的作用.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
02:41Telomeres and Telomerase
23.1K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.1K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K